Upcoming Discovery Events

Organ Modelling UK: In-Person

05 - 06 April 2022 |

BST (UTC+1)

05 - 06 April 2022

BST (UTC+1)

+ Digital Day: 07 April 2022 | Online

Bringing together expert leaders to discover the latest tools and strategies for advanced organ model development.

Discovery Europe: In-Person

09 - 10 June 2022 |

Berlin, Germany

09 - 10 June 2022

Berlin, Germany

+ Digital Day: 13 June 2022 | Online

Join and network with over 500 industry leaders at the renowned Drug Discovery Summit in Berlin, where we will address the latest advancements in target identification, validation and HIT optimisation.

Neuroscience Discovery Symposium

15 September 2022 |

Online: BST (UTC+1)

15 September 2022

Online: BST (UTC+1)

Discovery US: In-Person

November 2022 |

Boston, USA

November 2022

Boston, USA

500+ leaders, experts and scientists helping to shape the future of drug discovery and development

Upcoming Discussion Groups

Our monthly Discussion Groups are hosted by a panel of leading industry experts who explore some of the key issues facing Drug Discovery, Computational & Molecular Drug Design, as well as Medicinal Chemistry today.

Register below to receive a live stream of the discussion as well a complimentary report outlining the key findings and conclusions covered.

Advancing Targeted Protein Degradation in Drug Discovery

10 December 2021 | Online: 15:00 GMT / 10:00 EST / 07:00 PDT

This month’s discussion group focuses on novel methods for protein degradation and moving forward from the traditionally used E3 Ligases. Join our December discussion group to join the conversation with industry leaders and pioneers, learn about the latest market trends and developments, and explore the future of targeted protein degradation.

Panel Discussion

Drug Discovery – Modalities and New Mechanisms

–       New modalities e.g. Triple modalities

–       Novel E3 ligases development

–       Molecular glues update – moving towards rational design

Discussion Group Leader: Markus Schade, Senior Scientist, AstraZeneca

Panellists:

  • Joanne Wayne, Senior Scientist, Vernalis
  • Benedict Cross, Chief Technology Officer, Phoremost
  • Gustavo J. Gutierrez, Principal Scientist, Galapagos
  • Zhenyi (Jason) Hu, Postdoctoral Associate, Crews lab, Yale University
  • Magnus Walter, Head of Discovery Chemistry, Screening Biology & Operations, AbbVie
Neuroscience Drug Discovery Development

Taking place December 2021

Viewer Registration Coming Soon

Reports and write-ups pertaining to previous Discussion Groups are available in our Insights section.

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Download Series Agenda at a Glance

Submit your details to register your interest & to be kept up to date about relevant services or events. You may opt-out at any time. Please check our Privacy Policy to see how Oxford Global protects and manages your data.

Stay up to date

Sign up for our monthly Editorial Newsletter to keep up with all things Drug Discovery

Submit your details to receive the monthly newsletter & to be kept up to date about relevant events, monthly discussion groups and portal membership offers. You may opt-out at any time. Please check our Privacy Policy to see how Oxford Global protects and manages your data.